Navigation Links
Golden Meditech Chairman Increases Stake in Company
Date:10/27/2011

HONG KONG, Oct. 27, 2011 /PRNewswire-Asia-FirstCall/ -- Golden Meditech Holdings Limited ("Golden Meditech" or the "Company," -- 801.HK; 910801.TW), today announces that the Group's Chairman, Mr. KAM Yuen, and his family have purchased 53,828,000 shares of the Company from the open market on the disclosure date (October 27, 2011), at the average price of HK$0.85 per share via a representative holding company, as per disclosure to the Hong Kong Exchanges and Clearings Limited. As a result of which, Mr. Kam and family have increased their interest in the Company from 19.01% to 21.64%.

Mr. Kam is the founder of the Company and is currently serving as the Group's Chairman and Chief Executive Officer. Mr. Kam has over twenty years of experience in healthcare industry in China. Under his helm, the Group has grown from a single product medical devices producer to a leading healthcare enterprise in China and a leader in multiple markets, including medical devices, hospital management and cord blood banking.

About Golden Meditech Holdings Limited

Golden Meditech Holdings Limited is China's leading integrated-healthcare enterprise and a first-mover in the industry. Over the years, the Group has established dominant positions in different market segments including medical devices and healthcare-related services in umbilical cord blood banking and hospital operation, thanks to its strengths in innovation and market expertise and the ability to capture emerging market opportunities. Going forward, the Group will continue to pursue a leading position in China's healthcare industry both through organic growth and strategic expansion.

For enquiries, please contact:

Investor Relations Department
Golden Meditech Holdings Limited
Address: 48/F, Bank of China Tower, 1 Garden Road, Central, Hong Kong
Tel: +852-3605-8180
Fax: +852-3605-8181
Email: ir@goldenmeditech.com


'/>"/>
SOURCE Golden Meditech Holdings Limited
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Golden Meditech Announces Annual Results for FY 2009/10
2. Golden Meditech Announces Plan to Issue Taiwan Depository Receipts
3. Golden Meditech as First Chinese Healthcare Enterprise to Obtain Approval for Taiwan Depositary Receipts Offering
4. Golden Meditech to Form Strategic Alliance with Long Bon International
5. Golden Meditech Acquires Remaining Stake in Chinese Herbal Medicine Business
6. Fenwal, Golden Meditech Complete Definitive Agreement to Form Joint Venture in China
7. Golden Meditech Chairman Increases Stake in Company
8. Golden Meditech to Increase Stake in NYSE-listed Affiliate -- China Cord Blood Corporation to 39.5%
9. Golden Meditech Acquires Shanghai East International Medical Centre
10. Golden Meditech FY2010-11 Annual Results
11. Golden Meditech Celebrates Grand Opening of Taiwan Representative Office
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... , June 24, 2016   Pulmatrix, Inc ... company developing innovative inhaled drugs, announced today that it ... Russell Investments reconstituted its comprehensive set of U.S. ... "This is an important milestone for Pulmatrix," said ... increase shareholder awareness of our progress in developing drugs ...
(Date:6/24/2016)...  Arkis BioSciences, a leading innovator in the ... cerebrospinal fluid treatments, today announced it has secured ... led by Innova Memphis, followed by Angel Capital ... Arkis, new financing will accelerate the commercialization of ... of its in-licensed Endexo® technology. ...
(Date:6/23/2016)... 2016 Research and Markets has announced ... Forecast to 2022" report to their offering. ... the patients with kidney failure, it replaces the function of ... patient,s blood and thus the treatment helps to keep the ... balance. Increasing number of ESRD patients & ...
Breaking Medicine Technology:
(Date:6/24/2016)... ... June 24, 2016 , ... ... Sessions in Dallas that it will receive two significant new grants to support ... as PHA marked its 25th anniversary by recognizing patients, medical professionals and scientists ...
(Date:6/24/2016)... San Diego, CA (PRWEB) , ... June 24, 2016 , ... ... up with the American Cancer Society and the Road To Recovery® program to drive ... care to seniors and other adults to ensure the highest quality of life and ...
(Date:6/24/2016)... Norcross, Georgia (PRWEB) , ... June 24, 2016 ... ... Year” awards today at the Clinical Decision Making in Emergency Medicine conference in ... who have authored journal articles published in Emergency Medicine Practice and ...
(Date:6/24/2016)... ... June 24, 2016 , ... Strategic Capital Partners, ... economy by obtaining investment capital for emerging technology companies. SCP has delivered ... already resulted in more than a million dollars of capital investment for five ...
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... ... for human induced pluripotent stem (iPS) cells and other difficult to transfect cells, ... Cloning Medium. The PluriQ™ G9™ Gene Editing System is a complete ...
Breaking Medicine News(10 mins):